CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Crotonoside 25mg  | ≥95%

CSNpharm

Crotonoside is a naturally occurring active isomer of guanosine found in the seeds of Croton tiglium, which could reduce the blood pressure in rabbits and cats.

More Information Supplier Page

Crotonoside 50mg  | ≥95%

CSNpharm

Crotonoside is a naturally occurring active isomer of guanosine found in the seeds of Croton tiglium, which could reduce the blood pressure in rabbits and cats.

More Information Supplier Page

Crotonoside 5mg  | ≥95%

CSNpharm

Crotonoside is a naturally occurring active isomer of guanosine found in the seeds of Croton tiglium, which could reduce the blood pressure in rabbits and cats.

More Information Supplier Page

Crotonoside 100mg  | ≥95%

CSNpharm

Crotonoside is a naturally occurring active isomer of guanosine found in the seeds of Croton tiglium, which could reduce the blood pressure in rabbits and cats.

More Information Supplier Page

Cryptotanshinone 50mg  | ≥99%

CSNpharm

Cryptotanshinone is a potent STAT3 inhibitor (IC50 =4.6 μM) and inhibits STAT3 Tyr705 phosphorylation in DU145 prostate cancer cells. Cryptotanshinone showed inhibitory effect on PL(pro) with IC50 value of 0.8μM and slight inhibitory effect on 3CLpro with IC50 value of 226.7μM.

More Information Supplier Page

Cryptotanshinone 25mg  | ≥99%

CSNpharm

Cryptotanshinone is a potent STAT3 inhibitor (IC50 =4.6 μM) and inhibits STAT3 Tyr705 phosphorylation in DU145 prostate cancer cells. Cryptotanshinone showed inhibitory effect on PL(pro) with IC50 value of 0.8μM and slight inhibitory effect on 3CLpro with IC50 value of 226.7μM.

More Information Supplier Page

Cryptotanshinone 10mg  | ≥99%

CSNpharm

Cryptotanshinone is a potent STAT3 inhibitor (IC50 =4.6 μM) and inhibits STAT3 Tyr705 phosphorylation in DU145 prostate cancer cells. Cryptotanshinone showed inhibitory effect on PL(pro) with IC50 value of 0.8μM and slight inhibitory effect on 3CLpro with IC50 value of 226.7μM.

More Information Supplier Page

Crystal Violet 50mg  | Purity Not Available

CSNpharm

Crystal violet, a triphenylmethane dye, is used in histological staining and gram stain tests to distinguish between different classes of bacteria.

More Information Supplier Page

CTS-1027 5mg  | ≥98%

CSNpharm

CTS-1027 is a potent small molecule inhibitor of MMPs (IC50=0.4 nM/0.6 nM for MMP2/MMP13), displaying > 1,000 fold selectivity over MMP1.

More Information Supplier Page

CTS-1027 25mg  | ≥98%

CSNpharm

CTS-1027 is a potent small molecule inhibitor of MMPs (IC50=0.4 nM/0.6 nM for MMP2/MMP13), displaying > 1,000 fold selectivity over MMP1.

More Information Supplier Page

CTS-1027 50mg  | ≥98%

CSNpharm

CTS-1027 is a potent small molecule inhibitor of MMPs (IC50=0.4 nM/0.6 nM for MMP2/MMP13), displaying > 1,000 fold selectivity over MMP1.

More Information Supplier Page

CTS-1027 1mg  | ≥98%

CSNpharm

CTS-1027 is a potent small molecule inhibitor of MMPs (IC50=0.4 nM/0.6 nM for MMP2/MMP13), displaying > 1,000 fold selectivity over MMP1.

More Information Supplier Page

CTS-1027 10mg  | ≥98%

CSNpharm

CTS-1027 is a potent small molecule inhibitor of MMPs (IC50=0.4 nM/0.6 nM for MMP2/MMP13), displaying > 1,000 fold selectivity over MMP1.

More Information Supplier Page

CU-CPT-8m 5mg  | ≥99%

CSNpharm

CU-CPT8m is a Toll-like receptor 8 (TLR8) specific small-molecule inhibitor that exerts “potent anti-inflammatory effects” on the tissue of patients with arthritis.

More Information Supplier Page

CU-CPT-8m 100mg  | ≥99%

CSNpharm

CU-CPT8m is a Toll-like receptor 8 (TLR8) specific small-molecule inhibitor that exerts “potent anti-inflammatory effects” on the tissue of patients with arthritis.

More Information Supplier Page

CU-CPT-8m 50mg  | ≥99%

CSNpharm

CU-CPT8m is a Toll-like receptor 8 (TLR8) specific small-molecule inhibitor that exerts “potent anti-inflammatory effects” on the tissue of patients with arthritis.

More Information Supplier Page

CU-CPT-8m 10mg  | ≥99%

CSNpharm

CU-CPT8m is a Toll-like receptor 8 (TLR8) specific small-molecule inhibitor that exerts “potent anti-inflammatory effects” on the tissue of patients with arthritis.

More Information Supplier Page

Cuminaldehyde 1g  | ≥99%

CSNpharm

Cuminaldehyde, the major component of Cuminum cyminum, is a natural aldehyde with inhibitory effect on α-synuclein fibrillation and cytotoxicity.

More Information Supplier Page

Cuminaldehyde 5g  | ≥99%

CSNpharm

Cuminaldehyde, the major component of Cuminum cyminum, is a natural aldehyde with inhibitory effect on α-synuclein fibrillation and cytotoxicity.

More Information Supplier Page

Curculigoside 5mg  | ≥98%

CSNpharm

Curculigoside, a natural product isolated and purified from the rhizomes of Curculigo orchioides Gaertn., can prevent bone loss, improve osteogenesis and inhibit osteoclastogenesis of hAFSCs, suggesting its potential use to regulate hAFSC osteogenic differentiation for treating bone disorders.Curculigoside can also promote calcium deposition and increase the levels of ALP and Runx2 in osteoblasts under oxidative […]

More Information Supplier Page

Curculigoside 1mg  | ≥98%

CSNpharm

Curculigoside, a natural product isolated and purified from the rhizomes of Curculigo orchioides Gaertn., can prevent bone loss, improve osteogenesis and inhibit osteoclastogenesis of hAFSCs, suggesting its potential use to regulate hAFSC osteogenic differentiation for treating bone disorders.Curculigoside can also promote calcium deposition and increase the levels of ALP and Runx2 in osteoblasts under oxidative […]

More Information Supplier Page

Curculigoside 10mg  | ≥98%

CSNpharm

Curculigoside, a natural product isolated and purified from the rhizomes of Curculigo orchioides Gaertn., can prevent bone loss, improve osteogenesis and inhibit osteoclastogenesis of hAFSCs, suggesting its potential use to regulate hAFSC osteogenic differentiation for treating bone disorders.Curculigoside can also promote calcium deposition and increase the levels of ALP and Runx2 in osteoblasts under oxidative […]

More Information Supplier Page

Curcumol 10mg  | ≥98%

CSNpharm

Curcumol is a sesquiterpene originally isolated from curcuma rhizomes showing anticancer activities both in vitro and in vivo.

More Information Supplier Page

Curcumol 5mg  | ≥98%

CSNpharm

Curcumol is a sesquiterpene originally isolated from curcuma rhizomes showing anticancer activities both in vitro and in vivo.

More Information Supplier Page

CVT-313 50mg  | ≥98%

CSNpharm

CVT-313 is a potent, selective, ATP-competitive and reversible inhibitor of CDK2 with IC50 of 0.5 μM for Cdk2/A and Cdk2/E; 4.2 μM for Cdk1/B; 215 μM for Cdk4/D1.

More Information Supplier Page

CVT-313 25mg  | ≥98%

CSNpharm

CVT-313 is a potent, selective, ATP-competitive and reversible inhibitor of CDK2 with IC50 of 0.5 μM for Cdk2/A and Cdk2/E; 4.2 μM for Cdk1/B; 215 μM for Cdk4/D1.

More Information Supplier Page

CVT-313 5mg  | ≥98%

CSNpharm

CVT-313 is a potent, selective, ATP-competitive and reversible inhibitor of CDK2 with IC50 of 0.5 μM for Cdk2/A and Cdk2/E; 4.2 μM for Cdk1/B; 215 μM for Cdk4/D1.

More Information Supplier Page

CVT-313 10mg  | ≥98%

CSNpharm

CVT-313 is a potent, selective, ATP-competitive and reversible inhibitor of CDK2 with IC50 of 0.5 μM for Cdk2/A and Cdk2/E; 4.2 μM for Cdk1/B; 215 μM for Cdk4/D1.

More Information Supplier Page

CW069 2mg  | ≥99%

CSNpharm

CW069 is a selective and allosteric microtubule motor protein HSET inhibitor with IC50 value of 75 μM.

More Information Supplier Page

CW069 5mg  | ≥99%

CSNpharm

CW069 is a selective and allosteric microtubule motor protein HSET inhibitor with IC50 value of 75 μM.

More Information Supplier Page

CW069 10mg  | ≥99%

CSNpharm

CW069 is a selective and allosteric microtubule motor protein HSET inhibitor with IC50 value of 75 μM.

More Information Supplier Page

CX-6258 HCl 1mg  | ≥98%

CSNpharm

CX-6258 HCl is a potent, orally efficacious pan-Pim kinase inhibitor with IC50 of 5 nM, 25 nM and 16 nM for Pim1, Pim2, and Pim3, respectively.

More Information Supplier Page

CX-6258 HCl 5mg  | ≥98%

CSNpharm

CX-6258 HCl is a potent, orally efficacious pan-Pim kinase inhibitor with IC50 of 5 nM, 25 nM and 16 nM for Pim1, Pim2, and Pim3, respectively.

More Information Supplier Page